’ sdisease AlongitudinalstudyofanxietyandcognitivedeclineindementiawithLewybodiesandAlzheimer RESEARCHOpenAccess
Fulltekst
RELATERTE DOKUMENTER
CDR: Clinical Dementia Rating Scale; CERAD: Consortium to Establish a Registry for Alzheimer ’ s Disease; COWAT: Controlled Oral Word Association Test; CSF: Cerebrospinal fluid;
In particular, a significant proportion of patients with Alzheimer disease (AD) and Parkinson disease (PD), the 2 most prevalent neurodegenerative diseases, suffer chronic pain
HC healthy controls, MCI mild cognitive impairment, sMCI subjective MCI, aMCI amnestic MCI, AD Alzheimer’s disease, ADNI data from the Alzheimer’s Disease Neuroimaging Initiative,
KeywoRDS: Kynurenines, hallucinations, neuropsychiatric symptoms, kynurenic acid, kynurenine, Alzheimer’s disease, Lewy body dementia.. ReCeIveD: August
Patients with Huntington’s disease, and patients who had received a clinical diagnosis of mild cognitive impairment due to AD, were especially challenging as dementia in such cases
Based on the 1-year follow-up diagnosis the patients were divided into one mild cognitive impairment- dementia (MCI-DEM) group including those diagnosed with either MCI (n = 21;
A total of 24,638 participants of the HUNT Study were included in the present study, 579 of whom were diagnosed with Alzheimer disease, mixed Alzheimer/vascular dementia, or
Probable rapid eye movement sleep behavior disorder increases risk for mild cognitive impairment and Parkinson disease: A population-based study.. Mahlknecht P, Seppi K, Frauscher